Covid-19 Treatment Pipeline Review 2020

Table of Content:

1. Introduction
   1. Report Overview
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Industry Challenges
4. Key Insights
   1. COVID-19 Disease Overview
   2. Epidemiology and Outbreak Analysis of COVID 19 by Key Countries
   3. Comparison of COVID-19 Pandemic with Previous Pandemics such as SARS and MERS
   4. Steps being Taken by Governments to Develop a COVID-19 Treatment
   5. Key Industry Developments – Collaborations & Partnerships in COVID-19 Treatment Development
   6. Statistics on Ageing Population – For Key Countries
   7. Statistics on Prevalence of Chronic Diseases – For Key Countries
5. COVID-19 Treatment Pipeline Assessment
   1. By Molecule Type
   2. By Recruitment Status
   3. By Study Phase
   4. By Gender
   5. By Study Type
   6. By Sponsor
6. COVID-19 Treatment Company and Candidate Profiles
   1. Clinical Stage
      1. Hydroxychloroquine
         1. Company Overview
         2. Product Description
         3. R&D Status & Development Activities
         4. Mechanism of Action
         5. Molecule Type
         6. Stage of Development
         7. Indications
         8. Route of Administration
         9. Funding
      2. Chloroquine
         1. Company Overview
         2. Product Description
         3. R&D Status & Development Activities
         4. Mechanism of Action
         5. Molecule Type
         6. Stage of Development
         7. Indications
         8. Route of Administration
         9. Funding
      3. Lopinavir/Ritonavir
         1. Company Overview
         2. Product Description
         3. R&D Status & Development Activities
         4. Mechanism of Action
         5. Molecule Type
         6. Stage of Development
         7. Indications
         8. Route of Administration
         9. Funding
      4. Ribavirin
         1. Company Overview
         2. Product Description
         3. R&D Status & Development Activities
         4. Mechanism of Action
         5. Molecule Type
         6. Stage of Development
         7. Indications
         8. Route of Administration
         9. Funding
      5. Remdesivir
         1. Company Overview
         2. Product Description
         3. R&D Status & Development Activities
         4. Mechanism of Action
         5. Molecule Type
         6. Stage of Development
         7. Indications
         8. Route of Administration
         9. Funding
   2. Overview of Preclinical Candidates Under Development for COVID 19 Treatment
7. COVID-19 Treatment: An Overview on Dormant & Discontinued Pipeline Candidates
   1. Overview
   2. Product Description
   3. Reason for Discontinuation
8. COVID-19 Treatment: Additional Key Insights
   1. Addressable COVID-19 Treatment Market (US$ Bn and Number of Units)
9. COVID-19: News, Press Releases and Conference Details

Note:

1) This Table of Content is tentative and subject to change as the research progresses.

2) Please note that the drug candidates included as examples were in the pipeline when this TOC was designed and their status might have changed since then.